title: Prenatal exposure to antidepressants: how safe are they?
authors.forename: Meir
authors.initials: M
authors.lastname: Steiner
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000175:diagnosis*; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D002653:Child Behavior Disorders / Q000139:chemically induced* / Q000503:physiopathology*; D003511:Cyclohexanols / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007360:Intelligence / Q000187:drug effects* / Q000502:physiology*; D008297:Male; D009357:Neonatal Abstinence Syndrome / Q000175:diagnosis*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011297:Prenatal Exposure Delayed Effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D000069470:Venlafaxine Hydrochloride
chemical_list: D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride